Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Recurrent Unexplained Fever and Suspected Promazine Toxicity: Why Probable Neuroleptic Malignant Syndrome Was Left Undiagnosed in a Healthcare Worker.

Created on 08 Nov 2026

Authors

Simonas Makstutis, Suzy Collins

Published in

Cureus. Volume 18. Issue 11. Pages e119209. Epub Nov 05, 2026.

Abstract

Neuroleptic malignant syndrome (NMS) is a potentially fatal adverse reaction to dopamine-antagonist medication that can resemble sepsis. A 51-year-old woman working in healthcare experienced recurrent episodes of fever, confusion and muscle rigidity, with six hospital presentations over approximately 10 months. Her prescribed medicines included promazine and amitriptyline. During an earlier severe admission, she developed hyperthermia, agitation, shock, and a creatine kinase concentration of 7272 U/L, requiring intensive care. Investigations did not identify a unifying diagnosis. During the most recent admission, review of previous records and a non-judgemental discussion elicited possible use of additional medication for sleep and neuropathic pain, although the preparation and quantity remained unclear. Six months' supply of promazine had been approved and dispensed within the preceding three months, supporting increased access without establishing the amount ingested. The clinical pattern supported a working diagnosis of probable promazine-associated NMS, with possible concomitant amitriptyline toxicity. Promazine was discontinued three days after admission. At follow-up approximately six months later, the patient remained off promazine and reported sustained symptom resolution and no further hospital attendances. This case highlights the importance of considering NMS in unexplained fever during antipsychotic treatment, conducting repeated medication reviews, and asking sensitive questions, regardless of a patient's professional healthcare background.

PMID:
42999903
Bibliographic data and abstract were imported from PubMed on 08 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 9
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement